{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:44Z","timestamp":1793442704325,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12005285"],"award-info":[{"award-number":["12005285"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115422","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:08:45Z","timestamp":1790780925000},"page":"115422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Nanocrystal maturation in doxorubicin liposomes determines functional performance: real-time insights from in situ SAXS"],"prefix":"10.1016","volume":"399","author":[{"given":"Yiwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangliang","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2026.115422_bb0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4155\/bio.10.204","article-title":"In vitro and in vivo characterizations of PEGylated liposomal doxorubicin","volume":"3","author":"Jiang","year":"2011","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115422_bb0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","article-title":"Doxorubicin: nanotechnological overviews from bench to bedside","volume":"22","author":"Cagel","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.115422_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119566","article-title":"Rapid scale-up and production of active-loaded PEGylated liposomes","volume":"586","author":"Roces","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115422_bb0020","article-title":"Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective","volume":"4","author":"Gabizon","year":"2025","journal-title":"BMJ Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115422_bb0025","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1021\/acsnano.3c08290","article-title":"A design-conversed strategy establishes the performance safe space for doxorubicin nanosimilars","volume":"18","author":"Nagpal","year":"2024","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115422_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713612","article-title":"Differences in physico-chemical properties and immunological response in nanosimilar complex drugs: the case of liposomal doxorubicin","volume":"24","author":"Lipsa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.115422_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil \u00ae-the first FDA approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2026.115422_bb0040","first-page":"55","article-title":"Gelation of liposome interior. A novel method for drug encapsulation","volume":"312","author":"Lasic","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2026.115422_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2018.09.001","article-title":"Drug nanocrystallisation within liposomes","volume":"288","author":"Li","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115422_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010123","article-title":"Quantitative cryo-TEM reveals new structural details of Doxil-like PEGylated liposomal Doxorubicin formulation","volume":"13","author":"Nordstrom","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115422_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.11.021","article-title":"An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil\u00ae, Caelyx\u00ae, DOXOrubicin, and SinaDoxosome","volume":"221","author":"Wibroe","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115422_bb0060","article-title":"Folded, undulating, and fibrous doxorubicin sulfate crystals in liposomes","volume":"47","author":"Yamamoto","year":"2023","journal-title":"Nanomedicine (London)"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115422_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1208\/s12248-025-01058-1","article-title":"A comparative study on physicochemical and analytical characterizations of Doxil\u00ae and its generic drug products","volume":"27","author":"Eneli","year":"2025","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115422_bb0070","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acsomega.7b01235","article-title":"Cardinal role of intraliposome doxorubicin-sulfate nanorod crystal in Doxil properties and performance","volume":"3","author":"Wei","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.jconrel.2026.115422_bb0075","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejpb.2016.04.011","article-title":"Insights into composition\/structure\/function relationships of Doxil\u00ae gained from \u201chigh-sensitivity\u201d differential scanning calorimetry","volume":"104","author":"Wei","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115422_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2017.09.069","article-title":"Heating treatments affect the thermal behavior of doxorubicin loaded in PEGylated liposomes","volume":"534","author":"Perinelli","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115422_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113336","article-title":"Encapsulation of doxorubicin in magnesium acetate liposomes as a pH-sensitive drug carrier for tumor therapy","volume":"28","author":"Yang","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115422_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2009.05.036","article-title":"Liposome drugs\u2019 loading efficiency: a working model based on loading conditions and drug\u2019s physicochemical properties","volume":"139","author":"Zucker","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115422_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1107\/S1600576725003577","article-title":"Changes of the lipid membrane structures caused by chain-length-dependent doxorubicin embedment in PEGylated liposomes","volume":"58","author":"Kang","year":"2025","journal-title":"J. Appl. Crystallogr."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115422_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0005-2736(89)90329-5","article-title":"Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies","volume":"980","author":"Druckmann","year":"1989","journal-title":"BBA-Biomembranes"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115422_bb0105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s41365-020-00825-3","article-title":"BL19U2: small-angle X-ray scattering beamline for biological macromolecules in solution at SSRF","volume":"31","author":"Li","year":"2021","journal-title":"Nucl. Sci. Tech."},{"key":"10.1016\/j.jconrel.2026.115422_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1107\/S0021889809023863","article-title":"BioXTAS RAW, a software program for high-throughput automated small-angle X-ray scattering data reduction and preliminary analysis","volume":"42","author":"Nielsen","year":"2009","journal-title":"J. Appl. Crystallogr."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115422_bb0115","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1021\/acs.molpharmaceut.3c00396","article-title":"Small-angle X-ray scattering for PEGylated liposomal doxorubicin drugs: an analytical model comparison study","volume":"20","author":"Li","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115422_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1107\/S0021889804029206","article-title":"X-ray scattering from unilamellar lipid vesicles","volume":"38","author":"Brzustowicz","year":"2005","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jconrel.2026.115422_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0001-8686(97)00312-6","article-title":"Analysis of small-angle scattering data from colloids and polymer solutions: modeling and least-squares fitting","volume":"70","author":"Pedersen","year":"1997","journal-title":"Adv. Colloid Interf. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115422_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbagen.2015.09.012","article-title":"Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs","volume":"1860","author":"Schilt","year":"2016","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.jconrel.2026.115422_bb0135","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1107\/S1600576715016544","article-title":"SASfit: a tool for small-angle scattering data analysis using a library of analytical expressions","volume":"48","author":"Bressler","year":"2015","journal-title":"J. Appl. Crystallogr."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115422_bb0140","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.nano.2015.06.007","article-title":"In vitro experiments showing enhanced release of doxorubicin from Doxil\u00ae in the presence of ammonia may explain drug release at tumor site","volume":"11","author":"Silverman","year":"2015","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115422_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0005-2736(98)00175-8","article-title":"Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient","volume":"1415","author":"Li","year":"1998","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"54","key":"10.1016\/j.jconrel.2026.115422_bb0150","doi-asserted-by":"crossref","first-page":"9876","DOI":"10.1039\/D5CC02434J","article-title":"Nanomorphology tuning in doxorubicin-loaded liposomes via cooling-induced doxorubicin-crystallization and membrane phase transition","volume":"61","author":"Nishimura","year":"2025","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.jconrel.2026.115422_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2017.11.007","article-title":"Leakage kinetics of the liposomal chemotherapeutic agent Doxil: the role of dissolution, protonation, and passive transport, and implications for mechanism of action","volume":"269","author":"Russell","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115422_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2015.08.024","article-title":"Mechanistic model and analysis of doxorubicin release from liposomal formulations","volume":"217","author":"Fugit","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115422_bb0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1107\/S2056989018002955","article-title":"Crystal structure and conformational analysis of doxorubicin nitrate","volume":"74","author":"Mathivathanan","year":"2018","journal-title":"Acta. Crystallogr. E. Crystallogr. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:48:47Z","timestamp":1793440127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0168365926008266"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115422","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocrystal maturation in doxorubicin liposomes determines functional performance: real-time insights from in situ SAXS","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115422"}}